| Literature DB >> 28330271 |
Sobhy I I Abdel-Hafez1, Nivien A Nafady2, Ismail R Abdel-Rahim1, Abeer M Shaltout3, José-Antonio Daròs4, Mohamed A Mohamed1,3,4.
Abstract
Mycogenic synthesis of silver nanoparticles (Entities:
Keywords: Alternaria solani; Antifungal activity; Mycosynthesis; Pathogen; Silver nanoparticles
Year: 2016 PMID: 28330271 PMCID: PMC5031560 DOI: 10.1007/s13205-016-0515-6
Source DB: PubMed Journal: 3 Biotech ISSN: 2190-5738 Impact factor: 2.406
The composition of the isolated endophytic fungal taxa and frequency of colonization (%) per 40 segments
| Endophytic fungi | No. of records | Frequency (%) |
|---|---|---|
|
| 23 | 57.5 |
|
| 3 | 7.5 |
|
| 9 | 22.5 |
|
| 13 | 32.5 |
|
| 12 | 30 |
|
| 5 | 12.5 |
|
| 8 | 20 |
|
| 7 | 17.5 |
Fig. 1Mycosynthesis of AgNPs. a Formation of AgNPs. Erlenmeyer flasks containing (1) silver nitrate solution, (2) fungal extract, and (3) myconsynthesized AgNPs. b UV–vis spectra of the mycosynthesized AgNPs at different times, as indicated
Fig. 2a HR-TEM images of the mycosynthesized AgNPs at different scales (50, 20 and 5 nm), as indicated. b Particle size distribution analysis
Fig. 3Zeta potential measurements of the mycosynthesized AgNPs
Fig. 4Characterization of AgNPs. a Selected area of electron diffraction (SAED) pattern of randomly selected AgNPs. b X-ray diffraction patterns of AgNPs
Fig. 5Characterization of AgNPs by EDX analysis displaying the purity and chemical composition of the mycosynthesized AgNPs
Fig. 6Characterizations of AgNPs by FT-IR spectroscopy displaying the function groups present in the mycosynthesized AgNPs
Mean of inhibitory growth rate (%) of pathogenic Alternaria solani by the mycosynthesized AgNPs
| Pathogen | Treatments | Concentration | Inhibition rate (%) | ||
|---|---|---|---|---|---|
| 4 days | 6 days | 8 days | |||
|
| AgNPs | 1 mg/L | 43.6 ± 0.5 | 57.6 ± 0.7 | 57.8 ± 0.5 |
| Ridomil gold plus | 5 mg/L | 72.7 ± 0.4 | 80.0 ± 0.5 | 72.2 ± 0.5 | |
| 10 mg/L | 96.4 ± 0.5 | 94.1 ± 0.5 | 88.9 ± 1.2 | ||
| 2 g/L | 66.3 ± 0.2 | 68.2 ± 0.5 | 69.7 ± 1.2 | ||
|
| AgNPs | 1 mg/L | 28 ± 0.5 | 57.5 ± 0.5 | 55.6 ± 0.4 |
| 5 mg/L | 72 ± 0.5 | 78.75 ± 0.1 | 72.2 ± 0.5 | ||
| 10 mg/L | 94 ± 1.0 | 95 ± 0.2 | 87.8 ± 1.1 | ||
| Ridomil gold plus | 2 g/L | 64.3 ± 0.6 | 69.2 ± 0.3 | 68.9 ± 0.5 | |
|
| AgNPs | 1 mg/L | 45.5 ± 0.4 | 57.65 ± 1.2 | 57.8 ± 0.2 |
| 5 mg/L | 72.7 ± 0.5 | 76.47 ± 0.4 | 71.1 ± 0.5 | ||
| 10 mg/L | 94.5 ± 0.2 | 94.12 ± 0.2 | 88.5 ± 1.0 | ||
| Ridomil gold plus | 2 g/L | 63.3 ± 0.5 | 66.2 ± 0.5 | 70.7 ± 1.0 | |
Fig. 7FE-SEM micrographs of pathogenic Alternaria solani F11 (KT721909) hyphae. a Fungal hyphae before treatment with AgNPs which showing regular and smooth surface. b and c Fungal hyphae after treatment with AgNPs. Pores and cavities were formed on the surface
Fig. 8HR-TEM micrographs of pathogenic Alternaria solani F11 (KT721909) fungal cell. a Control sample of untreated fungi showing regular distribution and well distinguished cell components. b, c and d AgNPs treated Alternaria solani. b Numerous AgNPs accumulated on the outer region of the fungal cell wall. c Distribution the AgNPs in the cytoplasm and membrane. d Accumulation of AgNPs in the nucleus
Fig. 9Gel electrophoresis analysis of AgNPs on DNA. After electrophoresis, the 1 % agarose gel was stained with ethidium bromide. Lane 1, DNA size marker; lane 2, control DNA non-treated with AgNPs; lanes 3 to 6, DNA treated with AgNPs